1. NKF KDOQI Guidelines. National Kidney Foundation; 2002. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification.

2. Руководство по клиническому питанию. Под ред. Луфта В.М., Багненко С.Ф., Щербука Ю.А. СПб, 2010. 428 с.

3. Iorember FM. Malnutrition in Chronic Kidney Disease. Front Pediatr. 2018 Jun 20; 6: 161. doi: 10.3389/fped.2018.00161. PMID: 29974043; PMCID: PMC6019478

4. KDOQI Work Group. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis. 2009 Mar; 53(3 Suppl 2): S11 - 104. doi: 10.1053/j.ajkd.2008.11.017. PMID: 19231749

5. Rodig NM, McDermott KC, Schneider MF, et al. Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Pediatr Nephrol. 2014 Oct; 29(10): 1987 - 95. doi: 10.1007/s00467-014-2812-9. Epub 2014 Apr 12. PMID: 24728472; PMCID: PMC4470271

6. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter., Suppl. 2013; 3: 1 - 150

7. Айтбаев К.А., Муркамилов И.Т., Фомин В.В. Нефрогенная анемия: новые физиологические подходы к терапии на основе имитации гипоксических ответов/Альманах клинической медицины. 2017 Ноябрь; 45 (7): 565 - 574. doi: 10.18786/2072-0505-2017-45-7-565-574

8. Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL. CKiD (CKD in children) prospective cohort study: a review of current findings. Am J Kidney Dis. 2012 Dec; 60(6): 1002 - 11. doi: 10.1053/j.ajkd.2012.07.018. Epub 2012 Sep 28. PMID: 23022429; PMCID: PMC3496011

9. Clinical Pediatric Nephrology, ed 2. Informa Healthcare, 2007

10. Chesnaye N C, Schaefer F, Groothoff J W et al. Mortality risk in European children with end-stage renal disease on dialysis Kidney International (2016) 89, 1355 - 1362

11. USDRDS, Annual Report 2020 Annual Data Report//End Stage Renal Disease//7: ESRD among Children and Adolescent

12. Mitsnefes MM. Cardiovascular Disease in Children with Chronic Kidney Disease. J Am Soc Nephrol 23: 578 - 585, 2012

13. Misurac J. Chronic kidney disease in the neonate: etiologies, management, and outcomes. Semin Fetal Neonatal Med. 2017 Apr; 22(2): 98 - 103. doi: 10.1016/j.siny.2016.09.003. Epub 2016 Oct 10. PMID: 27733241

14. NAPRTCS, North American Pediatric Renal Trials and Collaborative Studies: 2011 Annual Dialysis Report, 2011

15. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012 Mar; 27(3): 363 - 73. doi: 10.1007/s00467-011-1939-1. Epub 2011 Jun 29. Erratum in: Pediatr Nephrol. 2012 Mar; 27(3): 507. PMID: 21713524; PMCID: PMC3264851

16. Xiao N, Jenkins TM, Nehus E, et al; Teen-LABS Consortium. Kidney function in severely obese adolescents undergoing bariatric surgery. Obesity (Silver Spring). 2014 Nov; 22(11): 2319 - 25. doi: 10.1002/oby.20870. PMID: 25376399; PMCID: PMC4225641

17. Ding W, Cheung WW, Mak RH: Impact of obesity on kidney function and blood pressure in children. World J Nephrol 2015; 4: 223 - 229

18. Vikse BE, Irgens LM, Leivestad T, et al. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol. 2008 Jan; 19(1): 151 - 7. doi: 10.1681/ASN.2007020252. Epub 2007 Dec 5. PMID: 18057216; PMCID: PMC2391041

19. Carmody JB, Charlton JR: Short-term gestation, long-term risk: prematurity and chronic kidney disease. Pediatrics 2013; 131: 1168 - 1179

20. USRDS. Annual data report. Chapter 7: ESRD among Children, Adolescents, and Young Adults. 2017

21. Wong CS, Gipson DS, Gillen DL, et al. Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis. 2000 Oct; 36(4): 811 - 9. doi: 10.1053/ajkd.2000.17674. PMID: 11007685

22. Mehta NM, Corkins MR, Lyman B, et al; American Society for Parenteral and Enteral Nutrition Board of Directors. Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions. JPEN J Parenter Enteral Nutr. 2013 Jul; 37(4): 460 - 81. doi: 10.1177/0148607113479972. Epub 2013 Mar 25. PMID: 23528324

23. Rees L., Bockenhauer D., Webb N.J.A., Punaro M.G. Oxford specialist Handbooks in paediatrics. Paediatric Nephrology. Third edition. PP 737

24. Gerson A, Hwang W, Fiorenza J, et al. Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis. 2004 Dec; 44(6): 1017 - 23. doi: 10.1053/j.ajkd.2004.08.024. PMID: 15558522

25. Perlman RL, Finkelstein FO, Liu L, et al. Quality of life in chronic kidney disease (CKD): a crossectional analysis in the Renal Research Institute-CKD study. American journal of kidney diseases. 2005; 45(4): 658 - 666. [PubMed: 15806468]

26. Jelkmann W. Regulation of erythropoietin production. J Physiol. 2011 Mar 15; 589 (Pt 6): 1251 - 8. doi: 10.1113/jphysiol.2010.195057. Epub 2010 Nov 15. PMID: 21078592; PMCID: PMC3082088

27. Atkinson MA, White CT. Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist. Pediatr Nephrol. 2012 Jan; 27(1): 33 - 40. doi: 10.1007/s00467-011-1832-y. Epub 2011 Mar 13. PMID: 21400189

28. Anemia in chronic kidney disease. Clinical Pediatric Nephrology, Third Ed. Edited By Kher KK, Schnaper HW, Greenbaum LA. CRC Press is an imprint of the Taylor & Francis Group, pp. 627 - 638

29. Mekahli D, Shaw V, Ledermann SE, Rees L. Long-term outcome of infants with severe chronic kidney disease. Clin J Am Soc Nephrol. 2010 Jan; 5(1): 10 - 7. doi: 10.2215/CJN.05600809. Epub 2009 Nov 12. PMID: 19965538; PMCID: PMC2801655

30. Greenbaum LA, A, Schneider MF, et al. The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol. 2011 Jan; 6(1): 14 - 21. doi: 10.2215/CJN.08481109. Epub 2010 Oct 28. PMID: 21030583; PMCID: PMC3022235

31. Cetin I, C, Calabrese S. Maternal predictors of intrauterine growth restriction. Curr Opin Clin Nutr Metab Care. 2013 May; 16(3): 310 - 9. doi: 10.1097/MCO.0b013e32835e8d9c. PMID: 23385473

32. Karlberg J, Schaefer F, Hennicke M, et al. Early age-dependent growth impairment in chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. Pediatr Nephrol. 1996 Jun; 10(3): 283 - 7. doi: 10.1007/BF00866761. PMID: 8792391

33. , B., Kiepe, D., Ciarmatori, S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr. Nephrol. 20, 279 - 289 (2005)

34. Haffner D, Schaefer F, Nissel R, et al. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. N Engl J Med. 2000 Sep 28; 343(13): 923 - 30. doi: 10.1056/NEJM200009283431304. PMID: 11006368

35. Isakova T, Nickolas TL, Denburg M, et al. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis. 2017 Dec; 70(6): 737 - 751.

36. Bacchetta J, Dubourg L, Harambat J, et al. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease. J Clin Endocrinol Metab. 2010 Apr; 95(4): 1741 - 8. doi: 10.1210/jc.2009-1576. Epub 2010 Feb 15. PMID: 20157196

37. van Husen M, Fischer AK, Lehnhardt A, et al. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int. 2010 Jul; 78(2): 200 - 6. doi: 10.1038Ai.2010.107. Epub 2010 Apr 21. PMID: 20407479

38. Sinha MD, Turner C, Dalton RN, et al. Investigating FGF-23 concentrations and its relationship with declining renal function in paediatric patients with pre-dialysis CKD Stages 3 - 5. Nephrol Dial Transplant. 2012 Dec; 27(12): 4361 - 8. doi: 10.1093/ndt/gfs109. Epub 2012 Apr 23. PMID: 22529162

39. Portale AA, Wolf M, H, et al. Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol. 2014 Feb; 9(2): 344 - 53. doi: 10.2215/CJN.05840513. Epub 2013 Dec 5. PMID: 24311704; PMCID: PMC3913243

40. Isakova T, Cai X, Lee J, et al; CRIC Study Investigators. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020 Feb; 75(2): 235 - 244. doi: 10.1053/j.ajkd.2019.07.022. Epub 2019 Oct 23. PMID: 31668375; PMCID: PMC7012684

41. Hsu CH, Patel SR, Young EW, Vanholder R (1994) The biological action of calcitriol in renal failure. Kidney Int 46: 605 - 612

42. Goodman WG, Quarles LD (2007) Development and progression of secondary hyperparathyroidism in chronic kidney disease: Lessons from molecular genetics. Kidney Int 74: 276 - 288

43. M, JL, Palma-Alvarez A, et al. Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure. Endocr Pathol. 2003 Spring; 14(1): 61 - 70. doi: 10.1385/ep:14:1:61. PMID: 12746564

44. Lewis R. Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management. Ann Clin Biochem. 2012 Sep; 49 (Pt 5): 432 - 40. doi: 10.1258/acb.2012.012004. Epub 2012 Jul 17. PMID: 22807503

45. Tian J, Niu L, An X. Cardiovascular risks in chronic kidney disease pediatric patients. Exp Ther Med. 2017 Nov; 14(5): 4615 - 4619. doi: 10.3892/etm.2017.5117. Epub 2017 Sep 15. PMID: 29201159

46. Azukaitis K, Jankauskiene A, Schaefer F, Shroff R. Pathophysiology and consequences of arterial stiffness in children with chronic kidney disease. Pediatr Nephrol. 2021 Jul; 36(7): 1683 - 1695. doi: 10.1007/s00467-020-04732-y. Epub 2020 Sep 7. PMID: 32894349

47. Segall L, Nistor I, Covic A. Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int. 2014; 2014: 937398. doi: 10.1155/2014/937398. Epub 2014 May 15. PMID: 24959595; PMCID: PMC4052068

48. Soylemezoglu O, Duzova A, F, Arinsoy T, G. Chronic renal disease in children aged 5 - 18 years: a population-based survey in Turkey, the CREDIT-C study. Nephrol Dial Transplant. 2012 Oct; 27 Suppl 3: iii146-51. doi: 10.1093/ndt/gfs366. PMID: 23115139.

49. Kaspar CD, Bholah R, Bunchman TE. A Review of Pediatric Chronic Kidney Disease. Blood Purif. 2016; 41(1-3): 211 - 7. doi: 10.1159/000441737. Epub 2016 Jan 15. PMID: 26766175

50. Chesnaye NC, van Stralen KJ, Bonthuis M, et al. Survival in children requiring chronic renal replacement therapy. Pediatr Nephrol. 2018 Apr; 33(4): 585 - 594. doi: 10.1007/s00467-017-3681-9. Epub 2017 May 15. PMID: 28508132; PMCID: PMC5859702

51. Tuttle KR, Alicic RZ, Duru OK, et al. Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry. JAMA Netw Open. 2019 Dec 2; 2(12): e1918169. doi: 10.1001/jamanetworkopen.2019.18169. PMID: 31860111; PMCID: PMC6991307

52. Tan SY, Naing L, Han A, et al. Chronic kidney disease in children and adolescents in Brunei Darussalam. World J Nephrol. 2016 Mar 6; 5(2): 213 - 9. doi: 10.5527/wjn.v5.i2.213. PMID: 26981447; PMCID: PMC4777794

53. Peco-Antic A, Bogdanovic R, Paripovic D, et al; Serbian Pediatric Registry of Chronic Kidney Disease (SPRECKID). Epidemiology of chronic kidney disease in children in Serbia. Nephrol Dial Transplant. 2012 May; 27(5): 1978 - 84. doi: 10.1093/ndt/gfr556. Epub 2011 Nov 3. PMID: 22058136

54. Baum M. Overview of chronic kidney disease in children. Curr Opin Pediatr. 2010 Apr; 22(2): 158 - 60. doi: 10.1097/MOP.0b013e32833695cb. PMID: 20299869; PMCID: PMC2880183

55. Томилина Н.А., Андрусев А.М., Перегудова Н.Г., Шинкарев М.Б. Заместительная терапия терминальной хронической почечной недостаточности в Российской Федерации в 2010 - 2015 гг. Отчет по данным Общероссийского Регистра заместительной почечной терапии Российского диализного общества. Часть первая. "Нефрология и Диализ" N 4, том 19, 2017 г.

56. De Alba Verduzco J, Hurtado EF, C, et al. Factors Associated With Anthropometric Indicators of Nutritional Status in Children With Chronic Kidney Disease Undergoing Peritoneal Dialysis, Hemodialysis, and After Kidney Transplant. J Ren Nutr. 2018 Sep; 28(5): 352 - 358. doi: 10.1053/j.jrn.2018.03.002. Epub 2018 May 11. PMID: 29759796

57. Franke D, Winkel S, Gellermann J, et al. Growth and maturation improvement in children on renal replacement therapy over the past 20 years. Pediatr Nephrol. 2013 Oct; 28(10): 2043 - 51. doi: 10.1007/s00467-013-2502-z. Epub 2013 May 25. PMID: 23708760

58. Harambat J, Bonthuis M, van Stralen KJ, et al; ESPN/ERA-EDTA Registry. Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Clin J Am Soc Nephrol. 2014 Jan; 9(1): 92 - 9. doi: 10.2215/CJN.00890113. Epub 2013 Oct 31. PMID: 24178977; PMCID: PMC3878688

59. Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr Nephrol. 2010 Sep; 25(9): 1699 - 706. doi: 10.1007/S00467-010-1538-6. Epub 2010 May 13. PMID: 20464428

60. Van Huis M, Bonthuis M, Sahpazova E, et al. Considerable variations in growth hormone policy and prescription in paediatric end-stage renal disease across European countries-a report from the ESPN/ERA-EDTA registry. Nephrol Dial Transplant. 2016 Apr; 31(4): 609 - 19. doi: 10.1093/ndt/gfv105. Epub 2015 Apr 28. PMID: 25925700

61. Atkinson MA, Ng DK, Warady BA, et al. The CKiD study: overview and summary of findings related to kidney disease progression. Pediatr Nephrol. 2021 Mar; 36(3): 527 - 538. doi: 10.1007/s00467-019-04458-6. Epub 2020 Feb 3. PMID: 32016626; PMCID: PMC7396280.

62. Chesnaye N, Bonthuis M, Schaefer F, et al; ESPN/ERA-EDTA registry. Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry. Pediatr Nephrol. 2014 Dec; 29(12): 2403 - 10. doi: 10.1007/s00467-014-2884-6. Epub 2014 Jul 21. PMID: 25039018

63. Pereira BJ. Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int. 2000 Jan; 57(1): 351 - 65. doi: 10.1046/j.1523-1755.2000.00840.x. PMID: 10620220

64. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012 Jan 14; 379(9811): 165 - 80. doi: 10.1016/S0140-6736(11)60178-5. Epub 2011 Aug 15. PMID: 21840587

65. Eknoyan G., Lameire N., Eckardt K. et al. KDIGO 2012 Clinical Practise Guidelines for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2013, 3, 5 - 14

66. Murton M, Goff-Leggett D, Bobrowska A, et al. Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review. Adv Ther. 2021 Jan; 38(1): 180 - 200. doi: 10.1007/s12325-020-01568-8. Epub 2020 Nov 24. PMID: 33231861; PMCID: PMC7854398

67. Piepsz A, Tondeur M, Ham H. Revisiting normal (51) Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging. 2006 Dec; 33(12): 1477 - 82. doi: 10.1007/s00259-006-0179-2. Epub 2006 Jul 25. PMID: 16865393

68. Brandt JR, Jacobs A, Raissy HH, et al. Orthostatic proteinuria and the spectrum of diurnal variability of urinary protein excretion in healthy children. Pediatr Nephrol. 2010 Jun; 25(6): 1131 - 7. doi: 10.1007/s00467-010-1451-z. Epub 2010 Feb 18. PMID: 20165888; PMCID: PMC3677044

69. Nelson Textbook of Pediatrics. Kliegman, ST Geme, Blum, Shah, Tasker, Wilson. 21th Ed. Elsvier, 2019. Ch. 55

70. Александров А.А., Кисляк О.А., Леонтьева И.В. от имени экспертов. Клинические рекомендации. Диагностика, лечение и профилактика артериальной гипертензии у детей и подростков. Системные гипертензии. 2020; 17 (2): 7 - 35. DOI: 10.26442/2075082X.2020.2.200126

71. Федеральные клинические рекомендации по оказанию медицинской помощи детям с хронической сердечной недостаточностью. Союз педиатров России, Ассоциация детских кардиологов России. 2014 г. https://minzdrav.gov-murman.ru/documents/poryadki-okazaniya-meditsinskoe-pomoshchi/_kr_hsn.pdf

72. Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidney J. 2016 Aug; 9(4): 583 - 91.

73. Masarone D, Valente F, Rubino M, et al. Pediatric Heart Failure: A Practical Guide to Diagnosis and Management. Pediatr Neonatol. 2017 Aug; 58(4): 303 - 312. doi: 10.1016/j.pedneo.2017.01.001. Epub 2017 Feb 1. PMID: 28279666

74. Furth SL, Abraham AG, Jerry-Fluker J, et al. Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol. 2011 Sep; 6(9): 2132 - 40. doi: 10.2215/CJN.07100810. Epub 2011 Aug 12. Erratum in: Clin J Am Soc Nephrol. 2014 May; 9(5): 997 - 8. PMID: 21841064; PMCID: PMC3358991

75. Harambat J, Kunzmann K, Azukaitis K, et al; 4C Study Consortium. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease. Kidney Int. 2017 Dec; 92(6): 1507 - 1514. doi: 10.1016/j.kint.2017.05.006. Epub 2017 Jul 18. PMID: 28729033

76. Kraut JA, Madias NE. Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease. Adv Chronic Kidney Dis. 2017 Sep; 24(5): 289 - 297. doi: 10.1053/j.ackd.2017.06.005. PMID: 29031355

77. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Working Group (2012) KDIGO Clinical Practice Guidelines for Anemia in Chronic Kidney Disease. Kidney Int Suppl 2: 279 - 335

78. Chronic Kidney Disease in Children (https://emedicine.medscape.com/article/984358-workup#showall)

79. Клинические рекомендации Анемия при хронической болезни почек. Разработано Национальным обществом детских гематологов, онкологов совместно с Национальным гематологическим обществом. 2020. https://cr.minzdrav.gov.ru/recomend/623_4

80. Atkinson MA, Warady BA. Anemia in chronic kidney disease. Pediatr Nephrol. 2018 Feb; 33(2): 227 - 238. doi: 10.1007/s00467-017-3663-y

81. Atkinson MA, Kim JY, Roy CN, et al. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort. Pediatr Nephrol. 2015 Apr; 30(4): 635 - 43. doi: 10.1007/s00467-014-2991-4. Epub 2014 Nov 8. PMID: 25380788; PMCID: PMC4336204

82. Ganz T, Nemeth E. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease. Semin Nephrol. 2016 Mar; 36(2): 87 - 93. doi: 10.1016/j.semnephrol.2016.02.001. PMID: 27236128; PMCID: PMC4884601

83. Youssef DM, Abdo H, Alakhras A, et al. Hepatitis C in children with chronic kidney disease: A single-center, Egypt. Saudi J Kidney Dis Transpl. 2017 Jan - Feb; 28(1): 102 - 106

84. Menon S, Munshi R. Blood-borne viral infections in pediatric hemodialysis. Pediatr Nephrol. 2019 Jun; 34(6): 1019 - 1031. doi: 10.1007/s00467-018-4019-y

85. Waller SL, Ralston AJ. The hourly rate of urinary amylase excretion, serum amylase, and serum lipase. I. In control subjects and patients with renal disease. Gut. 1971 Nov; 12(11): 878 - 83

86. Benito S, A, Unceta N, et al. Untargeted metabolomics for plasma biomarker discovery for early chronic kidney disease diagnosis in pediatric patients using LC-QTOF-MS. Analyst. 2018 Sep 10; 143(18): 4448 - 4458

87. Warady BA, Abraham AG, Schwartz GJ, et al. Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort. Am J Kidney Dis. 2015 Jun; 65(6): 878 - 88. doi: 10.1053/j.ajkd.2015.01.008

88. Zhang H, Tao Y, Wang Z, Lu J. Evaluation of nutritional status and prognostic impact assessed by the prognostic nutritional index in children with chronic kidney disease. Medicine (Baltimore). 2019 Aug; 98(34): e16713

89. Savant JD, Betoko A, Meyers KE, et al. Vascular Stiffness in Children With Chronic Kidney Disease. Hypertension. 2017 May; 69(5): 863 - 869

90. Escobedo-Monge MF, Ayala-Macedo G, Sakihara G, et al. Effects of Zinc Supplementation on Nutritional Status in Children with Chronic Kidney Disease: A Randomized Trial. Nutrients. 2019 Nov 5; 11(11): 2671

91. Snauwaert E, Van Biesen W, Raes A, et al. Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease. Pediatr Nephrol. 2018 Feb; 33(2): 315 - 323. doi: 10.1007/s00467-017-3802-5. Epub 2017 Sep 22. PMID: 28939943

92. Akchurin OM. Chronic Kidney Disease and Dietary Measures to Improve Outcomes. Pediatr Clin North Am. 2019 Feb; 66(1): 247 - 267. doi: 10.1016/j.pcl.2018.09.007. PMID: 30454747; PMCID: PMC6623973

93. Abuelo JG. Treatment of Severe Hyperkalemia: Confronting 4 Fallacies. Kidney Int Rep. 2017 Oct 7; 3(1): 47 - 55. doi: 10.1016/j.ekir.2017.10.001. PMID: 29340313; PMCID: PMC5762976

94. Thomsen RW, Nicolaisen SK, Hasvold P, et al. Elevated potassium levels in patients with chronic kidney disease: occurrence, risk factors and clinical outcomes-a Danish population-based cohort study. Nephrol Dial Transplant. 2018 Sep 1; 33(9): 1610 - 1620. doi: 10.1093/ndt/gfx312. PMID: 29177463

95. Saland JM, Pierce CB, Mitsnefes MM, et al; CKiD Investigators. Dyslipidemia in children with chronic kidney disease. Kidney Int. 2010 Dec; 78(11): 1154 - 63. doi: 10.1038/ki.2010.311. Epub 2010 Aug 25. PMID: 20736985; PMCID: PMC3222564

96. Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009 Nov; 4(11): 1832 - 43. doi: 10.2215/CJN.01640309. Epub 2009 Oct 9. PMID: 19820136

97. Schwartz GJ, A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009 Mar; 20(3): 629 - 37. doi: 10.1681/ASN.2008030287. Epub 2009 Jan 21. PMID: 19158356; PMCID: PMC2653687

98. Аверьянов С.Н., Амчеславский В.Г., Багаев В.Г. и др. Определение скорости клубочковой фильтрации у детей: история и современные подходы. Педиатрическая фармакология. 2018. 15(3): 218 - 223

99. De Souza VC, Rabilloud M, Cochat P, et al. Schwartz formula: is one k-coefficient adequate for all children? PLoS One. 2012; 7(12): e53439. doi: 10.1371/journal.pone.0053439. Epub 2012 Dec 28. PMID: 23285295; PMCID: PMC3532344

100. Selistre L, De Souza V, Cochat P, et al. GFR estimation in adolescents and young adults. J Am Soc Nephrol. 2012 Jun; 23(6): 989 - 96. doi: 10.1681/ASN.2011070705. Epub 2012 Apr 12. PMID: 22499586.

101. Schwartz GJ, Schneider MF, Maier PS, et al. Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin С Kidney Int. 2012 Aug; 82(4): 445 - 53. doi: 10.1038/ki.2012.169. PMID: 22622496; PMCID: PMC3433576

102. Inker LA, Heerspink HJL, Tighiouart H et al. GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials. J Am Soc Nephrol 2019; 30(9): 1735 - 1745. doi: 10.1681/ASN.2019010007

103. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987 Jun; 34(3): 571 - 90. doi: 10.1016/s0031-3955(16)36251-4. PMID: 3588043

104. Schnaper HW. Remnant nephron physiology and the progression of chronic kidney disease. Pediatr Nephrol. 2014 Feb; 29(2): 193 - 202. doi: 10.1007/s00467-013-2494-8. Epub 2013 May 29. PMID: 23715783; PMCID: PMC3796124

105. Weber JA, van Zanten AP. Interferences in current methods for measurements of creatinine. Clin Chem. 1991 May; 37(5): 695 - 700. PMID: 2032322

106. Schwartz GJ, Furth S, Cole SR, et al. Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int. 2006 Jun; 69(11): 2070 - 7. doi: 10.1038/sj.ki.5000385. PMID: 16612328

107. Интернет-калькулятор "bedside" формулы Шварца (2009) [Электронный ресурс]. URL: https://www.kidney.org/content/creatinine-based-"bedside-schwartz-equation-2009 (дата обращения: 13.07.2019)

108. Grubb A, Blimp-Jensen S, V, et al; IFCC Working Group on Standardisation of Cystatin C (WG-SCC). First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med. 2010 Nov; 48(11): 1619 - 21. doi: 10.1515/CCLM.2010.318. Epub 2010 Oct 29. PMID: 21034257

109. Байко С.В. Хроническая болезнь почек у детей: определение, классификация и диагностика/Нефрология и диализ. - Т. 22, N 1 2020, С. 53 - 70, DOI: 10.28996/2618-9801-2020-1-53-70

110. Клинические практические рекомендации KDIGO 2012 по диагностике и лечению хронической болезни почек: пер. с англ. Е.В. Захаровой. Нефрология и диализ. 2017. 19(1): 22 - 206

111. Brem AS. Neonatal hematuria and proteinuria. Clin Perinatol. 1981 Jun; 8(2): 321 - 32. PMID: 7273589

112. Hogg RJ, Furth S, Lemley KV, et al; National Kidney Foundation"s Kidney Disease Outcomes Quality Initiative. National Kidney Foundation"s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics. 2003 Jun; 111(6 Pt 1): 1416 - 21.

113. Hogg RJ, Portman RJ, Milliner D, et al. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics. 2000 Jun; 105(6): 1242 - 9. doi: 10.1542/peds.105.6.1242. PMID: 10835064

114. Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002 Mar; 39(3): 445 - 59. doi: 10.1053/ajkd.2002.31388. PMID: 11877563

115. Houser MT, Jahn MF, Kobayashi A, Walburn J. Assessment of urinary protein excretion in the adolescent: effect of body position and exercise. J Pediatr. 1986 Sep; 109(3): 556 - 61. doi: 10.1016/s0022-3476(86)80143-3. PMID: 3746552

116. Uchino S, Kellum JA, Bellomo R, et al; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005 Aug 17; 294(7): 813 - 8. doi: 10.1001/jama.294.7.813. PMID: 16106006

117. Mittalhenkle A, Stehman-Breen CO, Shlipak MG, et al. Cardiovascular risk factors and incident acute renal failure in older adults: the cardiovascular health study. Clin J Am Soc Nephrol. 2008 Mar; 3(2): 450 - 6. doi: 10.2215/CJN.02610607. Epub 2008 Feb 6. PMID: 18256380; PMCID: PMC2390946

118. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989 Jan 19; 320(3): 143 - 9. doi: 10.1056/NEJM198901193200303. PMID: 2643041

119. Browner WS, Li J, Mangano DT. In-hospital and long-term mortality in male veterans following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA. 1992 Jul 8; 268(2): 228 - 32. PMID: 1608142

120. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983 Feb; 74(2): 243 - 8. doi: 10.1016/0002-9343(83)90618-6. PMID: 6824004

121. Chronic kidney disease in children: Overview of management last updated: Jan 13, 2021 (https://www.uptodate.com/contents/chronic-kidney-disease-in-children-overview-of-management)

122. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2017 Jul; 7(1): 1 - 59. doi: 10.1016/j.kisu.2017.04.001. Epub 2017 Jun 21. Erratum in: Kidney Int Suppl (2011). 2017 Dec; 7(3): el. PMID: 30675420; PMCID: PMC6340919

123. Sabbagh Y, Graciolli FG, O"Brien S, et al. Repression of osteocyte signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res. 2012 Aug; 27(8): 1757 - 72. doi: 10.1002/jbmr. 1630. PMID: 22492547

124. Graciolli FG, Neves KR, Barreto F, et al. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease. Kidney international. 2017; 91(6): 1436 - 1446.

125. Gutierrez O, Isakova T, Rhee E, et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005 Jul; 16(7): 2205 - 15. doi: 10.1681/ASN.2005010052. Epub 2005 May 25. PMID: 15917335

126. Malluche HH, Porter DS, Pienkowski D. Evaluating bone quality in patients with chronic kidney disease. Nat Rev Nephrol. 2013 Nov; 9(11): 671 - 80. doi: 10.1038/nrneph.2013.198. Epub 2013 Oct 8. PMID: 24100399; PMCID: PMC4018981

127. Perwad F, Zhang MY, Tenenhouse HS, Portale AA. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin hydroxylase expression in vitro. American Journal of Physiology-Renal Physiology. 2007; 293(5): F1577 - F1583.

128. Shroff R, Wan M, Nagler EV, et al; European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders and Dialysis Working Groups. Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2 - 5 and on dialysis. Nephrol Dial Transplant. 2017 Jul 1; 32(7): 1098 - 1113. doi: 10.1093/ndt/gfx065. PMID: 28873969; PMCID: PMC5837199

129. Pediatric chronic kidney disease-mineral and bone disorder (CKD-MBD) https://www.uptodate.com/contents/pediatric-chronic-kidney-disease-mineral-and-bone-disorder-ckd-mbd?topicRef=128353&source=see_link

130. Sprague SM, Bellorin-Font E, Jorgetti V, et al. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis. Am J Kidney Dis. 2016 Apr; 67(4): 559 - 66. doi: 10.1053/j.ajkd.2015.06.023. Epub 2015 Aug 25. PMID: 26321176

131. Drube J, Wan M, Bonthuis M, et al; European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol. 2019 Sep; 15(9): 577 - 589. doi: 10.1038/s41581-019-0161-4. Epub 2019 Jun 13. PMID: 31197263; PMCID: PMC7136166

132. Chronic kidney disease in children: Clinical manifestations and evaluation last updated: Jan 20, 2021. (https://www.uptodate.com/contents/search?search=Chronic%20kidney%20disease%20in%20children:%20Clinical%20manifestations%20and%20evaluation&sp=0&searchType=PLAIN_TEXT&source=USER_INPUT&searchControl=TOP_PULLDOWN&searchOffset=1&autoComplete=false&language=ru&max=10&index=&autoCompleteTerm=)

133. Chronic Kidney Disease in Children Workup (https://emedicine.medscape.com/article/984358-workup#showall)

134. Chronic kidney disease in children: Overview of management (last updated: Jan 13, 2021) (https://www.uptodate.com/contents/chronic-kidney-disease-in-children-overview-of-management?sectionName=Slow%20progression%20of%20CKD&search=Chronic%20kidney%20disease%20in%20children:%20Clinical%20manifestations%20and%20evaluation&topicRef=128353&anchor=H5&source=see_link#H5)

135. Lurbe E, Agabiti-Rosei E, Cruickshank JK, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016 Oct; 34 (10): 1887 - 920. doi: 10.1097/HJH.0000000000001039. PMID: 27467768

136. Stewart GA, Gansevoort RT, Mark PB, et al. Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 2005 Jan; 67 (1): 217 - 26

137. Bosch A, Ulmer HE, Keller HE, et al. Electrocardiographic monitoring in children with chronic renal failure. Pediatr Nephrol. 1990 Mar; 4 (2): 140 - 4. doi: 10.1007/BF00858825. PMID: 2397180

138. Chronic kidney disease in children: Complications (last updated: Jan 13, 2021) (https://www.uptodate.com/contents/chronic-kidney-disease-in-children-complications?topicRef=6085&source=see_link)

139. El-Gamasy MA, Mawlana WH. Risk factors and prevalence of cardiac diseases in Egyptian pediatric patients with end-stage renal disease on regular hemodialysis. Saudi J Kidney Dis Transpl. 2019 Jan-Feb; 30 (1): 53 - 61

140. de Ruiter A, Bello A, Braam B. Fluid management in chronic kidney disease: what is too much, what is the distribution, and how to manage fluid overload in patients with chronic kidney disease? Curr Opin Nephrol Hypertens. 2020 Nov; 29 (6): 572 - 580. doi: 10.1097/MNH.0000000000000640. PMID: 32889980

141. Van Dyck M., Proesmans W. Head circumference in chronic renal failure from birth//Clinical nephrology. - 2001. - T. 56. - N. 6. - С. S13 - 6. - 3B

142. Dasgupta I, Keane D, Lindley E, et al. Validating the use of bioimpedance spectroscopy for assessment of fluid status in children. Pediatr Nephrol. 2018 Sep; 33 (9): 1601 - 1607

143. Hartung EA, Erus G, Jawad AF, et al. Brain Magnetic Resonance Imaging Findings in Children and Young Adults With CKD. Am J Kidney Dis. 2018 Sep; 72 (3): 349 - 359. doi: 10.1053/j.ajkd.2017.11.024

144. Matsuda-Abedini M, Fitzpatrick K, Harrell WR, et al. Brain abnormalities in children and adolescents with chronic kidney disease. Pediatr Res. 2018 Sep; 84 (3): 387 - 392. doi: 10.1038/s41390-018-0037-5

145. Kupferman JC, Matheson MB, Lande MB, et al. Increased history of ischemic stroke and decreased neurocognitive performance in children with chronic kidney disease. Pediatr Nephrol. 2020 Jul; 35 (7): 1315 - 1321

146. Miglinas M, Cesniene U, Janusaite MM, Vinikovas A. Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients. Front Cardiovasc Med. 2020 Jun 3; 7: 96. doi: 10.3389/fcvm.2020.00096. PMID: 32582768; PMCID: PMC7283453

147. Deva R, Alias MA, Colville D, et al. Vision-threatening retinal abnormalities in chronic kidney disease stages 3 to 5. Clin J Am Soc Nephrol. 2011 Aug; 6 (8): 1866 - 71

148. Farrah TE, Dhillon B, Keane PA, et al. The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons. Kidney Int. 2020 Aug; 98 (2): 323 - 342. doi: 10.1016/j.kint.2020.01.039

149. Nelms CL, Shaw V, Greenbaum LA, et al. Assessment of nutritional status in children with kidney diseases - clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2021 Apr; 36 (4): 995 - 1010. doi: 10.1007/s00467-020-04852-5. Epub 2020 Dec 14. PMID: 33319327; PMCID: PMC7910229

150. KHA-CARI. The CARI Guidelines. Evaluation and management of nutrition in children. CARI.org.au

151. Trace, S. et al. Clinical guideline. Monitoring growth in children with chronic kidney disease. BSPED.org.uk https://www.bsped.org.uk/media/1436/growth monitoring in children with chronic kidney disease.pdf (2018)

152. De Sanctis V, Di Maio S, Soliman AT, et al. Hand X-ray in pediatric endocrinology: Skeletal age assessment and beyond. Indian J Endocrinol Metab. 2014 Nov; 18 (Suppl 1): S63 - 71. doi: 10.4103/2230-8210.145076. PMID: 25538880; PMCID: PMC4266871

153. National Kidney Foundation (2009) KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. Am J Kidney Dis. 53 (suppl 2): S1 - S124

154. Chen W, Ducharme-Smith K, Davis L. Dietary sources of energy and nutrient intake among children and adolescents with chronic kidney disease. Pediatr Nephrol. 2017 Jul; 32 (7): 1233 - 1241. doi: 10.1007/s00467-017-3580-0. Epub 2017 Feb 16. PMID: 28210840; PMCID: PMC5633852

155. Webster AC, Nagler EV, Monon RL, Masson P. Chronic Kidney Disease. Lancet: 238 - 1252

156. Yang Y, Zhang Z, Zhuo L et al. The Spectrum of Biopsy-Proven Glomerular Disease in China: A Systematic Review. Chin Med J (Engl) doi: 10.4103/0366-6999.22690661

157. Rychlik I, E, Tesar V et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994 - 2000. Nephrol Dial Transplant. Haider DG, Masghati S, Goliasch G et al. Kidney biopsy results versus clinical parameters on mortality and ESRD progression in 2687 patients with glomerulonephritis. Corapi KM, Chen JL, Balk EM, Gordon CE. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis 73. doi: 10.1053/j.ajkd.2012.02.330

158. Evenepoel P, Behets GJS, Laurent MR, D"Haese PC. Update on the role of bone biopsy in the management of patients with CKD-MBD. J Nephrol. 2017 Oct; 30 (5): 645 - 652. doi: 10.1007/s40620-017-0424-8. Epub 2017 Aug 22. PMID: 28831679

159. Evenepoel P, D"Haese P, Bacchetta J, et al; ERA-EDTA Working Group on CKD-MBD. Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper. Nephrol Dial Transplant. 2017 Oct 1; 32 (10): 1608 - 1613. doi: 10.1093/ndt/gfw468. PMID: 28339949

160. Noto R, Maneatis T, Frane J, et al. Intracranial hypertension in pediatric patients treated with recombinant human growth hormone: data from 25 years of the Genentech National Cooperative Growth Study. J Pediatr Endocrinol Metab. 2011; 24 (9 - 10): 627 - 31. doi: 10.1515/jpem.2011.319. PMID: 22145447

161. Haffner D, Zivicnjak M. Pubertal development in children with chronic kidney disease. Pediatr Nephrol. 2017 Jun; 32 (6): 949 - 964. doi: 10.1007/s00467-016-3432-3. Epub 2016 Jul 27. PMID: 27464647

162. Shaw V, Polderman N, Renken-Terhaerdt J, et al. Energy and protein requirements for children with CKD stages 2 - 5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2020 Mar; 35 (3): 519 - 531

163. Nguyen L, Levitt R, Mak RH. Practical Nutrition Management of Children with Chronic Kidney Disease. Clinical Medicine Insights: Urology. 2016; 9: CMU. S13180

164. Desloovere A, Renken-Terhaerdt J, Tuokkola J. The dietary management of potassium in children with CKD stages 2 - 5 and on dialysis - clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2021 Jun; 36 (6): 1331 - 1346.

165. Palmer BF, Clegg DJ. Hyperkalemia across the Continuum of Kidney Function. Clin J Am Soc Nephrol. 2018 Jan 6; 13 (1): 155 - 157. doi: 10.2215/CJN.09340817. Epub 2017 Nov 7. PMID: 29114006; PMCID: PMC5753321

166. Harel Z, Harel S, Shah PS, et al. Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review. Am J Med. 2013 Mar; 126 (3): 264. e9 - 24. doi: 10.1016/j.amjmed.2012.08.016. Epub 2013 Jan 12. PMID: 23321430

167. Rees L, Schaefer F, Schmitt CP, et al. Chronic dialysis in children and adolescents: challenges and outcomes. Lancet Child Adolesc Health. 2017 Sep; 1 (1): 68 - 77. doi: 10.1016/S2352-4642(17)30018-4. Epub 2017 Jul 20. PMID: 30169229

168. Shroff R, Long DA, Shanahan C. Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol. 2013 Feb; 24 (2): 179 - 89. doi: 10.1681/ASN.2011121191. Epub 2012 Nov 8. PMID: 23138485

169. Fathallah-Shaykh S, Drozdz D, Flynn J, Jenkins R, Wesseling-Perry K, Swartz SJ, Wong C, Accomando B, Cox GF, Warady BA. Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease. Pediatr Nephrol. 2018 Feb; 33 (2): 325 - 333

170. Haffner D, Rees L. Growth and Puberty in Chronic Kidney Disease In: Geary DF, Schaefer F, eds. Pediatric Kidney Disease. Berlin, Heidelberg: Springer Berlin Heidelberg; 2016: 1425 - 1454

171. Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). American journal of hypertension. 2012; 25 (1): 1 - 15. [PubMed: 22068710]

172. medscape.com [Internet]. Gunnerson KJ. Lactic acidosis [cited 2016 Jul 16]. Available from: http://emedicine.medscape.com/article/167027-overview

173. belmapo.by [интернет]. Сапотницкий А.В., Шишко Г.А., Устинович Ю.А. Новые подходы к диагностике причин метаболического ацидоза в интенсивной терапии новорожденных: анионный промежуток плазмы крови. [Sapotnitsky AV, Shishko GA, Ustinovich YA. New approaches to the diagnosis of the causes metabolic acidosis in the neonatal intensive care: anion gap. (In Russ).] Доступно по: http://belmapo.by/downloads/neonatalogii/2013/novie_podhodi.pdf. Доступ на 16.07.2016

174. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis. 2003 Nov; 42 (5): 864 - 81. doi: 10.1016/j.ajkd.2003.07.016. PMID: 14582032

175. https://www.uptodate.com/contents/vitamin-b6-pyridoxine-pediatric-drug-information?search=pyridoxine&source=panel_search_result&selectedTitle=2~148&usage_type=panel&kp_tab=drug_pediatric&display_rank=1

176. Rees L, Shaw V, Qizalbash L, et al; Pediatric Renal Nutrition Taskforce. Delivery of a nutritional prescription by enteral tube feeding in children with chronic kidney disease stages 2 - 5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2021 Jan; 36 (1): 187 - 204. doi: 10.1007/s00467-020-04623-2. Epub 2020 Jul 29. PMID: 32728841; PMCID: PMC7701061

177. Nelms CL. Optimizing Enteral Nutrition for Growth in Pediatric Chronic Kidney Disease (CKD). Front Pediatr. 2018 Aug 2; 6: 214. doi: 10.3389/fped.2018.00214. PMID: 30116725; PMCID: PMC6083216

178. Rees L., Bockenhauer D., Webb N. J.A., Punaro M.G. Oxford specialist Handbooks in paediatrics. Paediatric Nephrology. Third edition. 2019. PP 737

179. Rees L, Jones H. Nutritional management and growth in children with chronic kidney disease. Pediatr Nephrol. 2013 Apr; 28 (4): 527 - 36. doi: 10.1007/s00467-012-2258-x. Epub 2012 Jul 24. PMID: 22825360

180. Rees L, Azocar M, Borzych D, et al; International Pediatric Peritoneal Dialysis Network (IPPN) registry. Growth in very young children undergoing chronic peritoneal dialysis. J Am Soc Nephrol. 2011 Dec; 22 (12): 2303 - 12. doi: 10.1681/ASN.2010020192. Epub 2011 Oct 21. PMID: 22021715; PMCID: PMC3279935

181. Warady BA, Silverstein DM. Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease. Pediatr Nephrol. 2014 Sep; 29 (9): 1493 - 505. doi: 10.1007/s00467-013-2557-x. Epub 2013 Sep 5. PMID: 24005791

182. Flynn JT, Carroll MK, Ng DK, et al. Achieved clinic blood pressure level and chronic kidney disease progression in children: a report from the Chronic Kidney Disease in Children cohort. Pediatr Nephrol. 2021 Jun; 36 (6): 1551 - 1559. doi: 10.1007/s00467-020-04833-8. Epub 2020 Nov 16. PMID: 33200315; PMCID: PMC8087620

183. Батурин А.К., Гаппаров М.Г., Каганов Б.С. и др. Методические рекомендации 2.3.1.2432-08 Рациональное питание. Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации. Дата введения 2008-12-18 https://docs.cntd.ru/document/1200076084

184. Bartter and Gitelman syndromes in children: Clinical manifestations, diagnosis, and management Author: Martin Konrad, MDSection Editor: Patrick Niaudet, MDDeputy Editor: Melanie S Kim, MD https://www.uptodate.com/contents/bartter-and-gitelman-syndromes-in-children-clinical-manifestations-diagnosis-and-management?search=Bartter%20and%20Gitelman%20syndromes&source=search_result&selectedTitle=3~47&usage_type=default&display_rank=3

185. Etiology and clinical manifestations of renal tubular acidosis in infants and children Author: Tej K Mattoo, MD, DCH, FRCPSection Editor: F Bruder Stapleton, MDDeputy Editor: Melanie S Kim, MD https://www.uptodate.com/contents/etiology-and-clinical-manifestations-of-renal-tubular-acidosis-in-infants-and-children?search=%22Etiology%20and%20clinical%20manifestations%20of%20renal%20tubular%20acidosis%20in%20infants%20and%20children&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 (last updated: Sep 18, 2019)

186. Nomura K, Asayama K, Jacobs L, Thijs L, Staessen JA. Renal function in relation to sodium intake: a quantitative review of the literature. Kidney Int. 2017 Jul; 92 (1): 67 - 78. doi: 10.1016/j.kint.2016.11.032. Epub 2017 Apr 12. PMID: 28412019

187. Ha IS, Yap HK, Munarriz RL, et al; International Pediatric Peritoneal Dialysis Network Registry. Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis. Kidney Int. 2015 Sep; 88 (3): 605 - 13. doi: 10.1038/ki.2015.108. Epub 2015 Apr 15. PMID: 25874598; PMCID: PMC4558567

188. Wang K, Jiang Y, Lai Y, Shen Y. Nutrition imbalance in Chinese chronic kidney disease children. Pediatr Int. 2018 Sep; 60 (9): 849 - 854. doi: 10.1111/ped.13642. Epub 2018 Sep 5. PMID: 29931711

189. Park J, Ahmadi SF, Streja E, et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis. 2014 Jan-Feb; 56 (4): 415 - 25. doi: 10.1016/j.pcad.2013.10.005. Epub 2013 Oct 9. PMID: 24438733; PMCID: PMC4733536

190. Inotropic agents in heart failure with reduced ejection fraction https://www.uptodate.com/contents/inotropic-agents-in-heart-failure-with-reduced-ejection-fraction?search=heart%20failure%20children&topicRef=1619&source=related_link

191. Bacchetta J. et al. Hyperphosphatemia and chronic kidney disease: a major daily concern both in adults and in children//Calcified tissue international. - 2021. - T. 108. - N 1. - С. 116 - 127. - 5C

192. Block GA, Wheeler DC, Persky MS, et al. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol. 2012 Aug; 23 (8): 1407 - 15. doi: 10.1681/ASN.2012030223. Epub 2012 Jul 19. PMID: 22822075; PMCID: PMC3402292

193. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003 Oct; 42 (4 Suppl 3): S1 - 201. PMID: 14520607

194. Kopple JD. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2001 Jan; 37 (1 Suppl 2): S66 - 70. doi: 10.1053/ajkd.2001.20748. PMID: 11158865

195. Moe SM, Zidehsarai MP, Chambers MA, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011 Feb; 6 (2): 257 - 64. doi: 10.2215/CJN.05040610. Epub 2010 Dec 23. PMID: 21183586; PMCID: PMC3052214

196. de Fornasari ML, Dos Santos Sens YA. Replacing Phosphorus-Containing Food Additives With Foods Without Additives Reduces Phosphatemia in End-Stage Renal Disease Patients: A Randomized Clinical Trial. J Ren Nutr. 2017 Mar; 27 (2): 97 - 105. doi: 10.1053/j.jrn.2016.08.009. Epub 2016 Oct 14. PMID: 27751628

197. Sullivan C, Sayre SS, Leon JB, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA. 2009 Feb 11; 301 (6): 629 - 35. doi: 10.1001/jama.2009.96. PMID: 19211470

198. Murali KM, Mullan J, Roodenrys S et al. Strategies to improve dietary, fluid, dialysis or medication adherence in patients with end stage kidney disease on dialysis: A systematic review and meta-analysis of randomized intervention trials. PLoS One 2019; 14(1): e0211479. doi: 10.1371/journal.pone.0211479

199. Caldeira D, Amaral T, David C, Sampaio C. Educational strategies to reduce serum phosphorus in hyperphosphatemic patients with chronic kidney disease: systematic review with meta-analysis. J Ren Nutr. 2011 Jul; 21 (4): 285 - 94. doi: 10.1053/j.jrn.2010.11.006. Epub 2011 Mar 23. PMID: 21429764

200. Shi Y, Zhao Y, Liu J, et al. Educational intervention for metabolic bone disease in patients with chronic kidney disease: a systematic review and meta-analysis. J Ren Nutr. 2014 Nov; 24 (6): 371 - 84. doi: 10.1053/j.jrn.2014.06.007. Epub 2014 Sep 3. PMID: 25193107

201. Milazi M, Bonner A, Douglas C. Effectiveness of educational or behavioral interventions on adherence to phosphate control in adults receiving hemodialysis: a systematic review. JBI Database System Rev Implement Rep 2017; 15 (4): 971 - 1010. doi: 10.11124/JBISRIR-2017-003360

202. Karavetian M, de Vries N, Rizk R, Elzein H. Dietary educational interventions for management of hyperphosphatemia in hemodialysis patients: a systematic review and meta-analysis. Nutr Rev. 2014 Jul; 72 (7): 471 - 82. doi: 10.1111/nure.12115. Epub 2014 Jun 11. PMID: 24920494

203. Gutekunst L. An Update on Phosphate Binders: A Dietitian"s Perspective. J Ren Nutr. 2016 Jul; 26 (4): 209 - 18. doi: 10.1053/j.jrn.2016.01.009. Epub 2016 Feb 23. PMID: 26920090

204. Klaus G, Watson A, Edefonti A, et al; European Pediatric Dialysis Working Group (EPDWG). Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol. 2006 Feb; 21 (2): 151 - 9. doi: 10.1007/s00467-005-2082-7. Epub 2005 Oct 25. PMID: 16247644; PMCID: PMC1766475

205. Mahdavi H, Kuizon BD, Gales B, Wang HJ, Elashoff RM, Salusky IB. Sevelamer hydrochloride: an effective phosphate binder in dialyzed children. Pediatr Nephrol. 2003 Dec; 18 (12): 1260 - 4. doi: 10.1007/s00467-003-1298-7. Epub 2003 Oct 30. PMID: 14586677

206. Shroff R, Wan M, Nagler EV, et al. Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2 - 5 and on dialysis. Nephrol Dial Transplant. 2017; 32 (7): 1114 - 1127. doi: 10.1093/ndt/gfx080-5C

207. Cardoso MP, Pereira LAL. Native vitamin D in pre-dialysis chronic kidney disease. Nefrologia (Engl Ed). 2019 Jan-Feb; 39 (1): 18 - 28. English, Spanish. doi: 10.1016/j.nefro.2018.07.004. Epub 2018 Sep 28. PMID: 30274806

208. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=4b66f795-e44a-4920-acd3-1977061f1cb3&t=

209. Ennis JL, Worcester EM, Coe FL, Sprague SM. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. J Nephrol. 2016 Feb; 29(1): 63 - 70. doi: 10.1007/s40620-015-0186-0. Epub 2015 Mar 4. PMID: 25736620

210. Webb NJA, Lerner G, Warady BA, et al. Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatr Nephrol. 2017 Jul; 32 (7): 1221 - 1232. doi: 10.1007/s00467-017-3579-6

211. Duranton F, Rodriguez-Ortiz ME, Duny Y, et al. Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis. Am J Nephrol. 2013; 37 (3): 239 - 48. doi: 10.1159/000346846. Epub 2013 Mar 5. PMID: 23467111

212. Li XH, Feng L, Yang ZH, Liao YH. Effect of active vitamin D on cardiovascular outcomes in predialysis chronic kidney diseases: A systematic review and meta-analysis. Nephrology (Carlton). 2015 Oct; 20 (10): 706 - 714. doi: 10.1111/nep.12505. PMID: 25963841

213. Hu X, Shang J, Yuan W, et al. Effects of paricalcitol on cardiovascular outcomes and renal function in patients with chronic kidney disease: A meta-analysis. Herz. 2018 Sep; 43 (6): 518 - 528. English. doi: 10.1007/s00059-017-4605-y. Epub 2017 Aug 23. PMID: 28835982

214. Liu Y, Liu LY, Jia Y, et al. Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis. Drug Des Devel Ther. 2019 Mar 28; 13: 999 - 1009. doi: 10.2147/DDDT.S176257. PMID: 30992658; PMCID: PMC6445244

215. Zheng Z, Shi H, Jia J, et al. Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies. BMC Nephrol. 2013 Sep 25; 14: 199. doi: 10.1186/1471-2369-14-199. PMID: 24066946; PMCID: PMC3851063

216. Zhang T, Ju H, Chen H, Wen W. Comparison of Paricalcitol and Calcitriol in Dialysis Patients With Secondary Hyperparathyroidism: A Meta-Analysis of Randomized Controlled Studies. Ther Apher Dial. 2019 Feb; 23 (1): 73 - 79. doi: 10.1111/1744-9987.12760. Epub 2018 Oct 16. PMID: 30328270

217. Cai P, Tang X, Qin W, Ji L, Li Z. Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Int Urol Nephrol. 2016 Apr; 48 (4): 571 - 84. doi: 10.1007/s11255-015-1195-6. Epub 2016 Jan 9. PMID: 26748501

218. Xie Y, Su P, Sun Y, Zhang H, Zhao R, Li L, Meng L. Comparative efficacy and safety of paricalcitol versus vitamin D receptor activators for dialysis patients with secondary hyperparathyroidism: a meta-analysis of randomized controlled trials. BMC Nephrol. 2017 Aug 25; 18 (1): 272. doi: 10.1186/s12882-017-0691-6. PMID: 28841848; PMCID: PMC5574209

219. Warady BA, Ng E, Bloss L, et al. Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis. Pediatr Nephrol. 2020 Sep; 35 (9): 1679 - 1697. doi: 10.1007/s00467-020-04516-4. Epub 2020 May 4. PMID: 32367309; PMCID: PMC7385021

220. Wesseling K, Bakkaloglu S, Salusky I. Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol. 2008 Feb; 23 (2): 195 - 207. doi: 10.1007/s00467-007-0671-3. Epub 2007 Nov 28. PMID: 18046581; PMCID: PMC2668632

221. McAlister L, Pugh P, Greenbaum L, et al. The dietary management of calcium and phosphate in children with CKD stages 2 - 5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce. Pediatr Nephrol. 2020 Mar; 35 (3): 501 - 518. doi: 10.1007/s00467-019-04370-z

222. Schmitt CP, Ardissino G, Testa S, Claris-Appiani A, Mehls O. Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr Nephrol. 2003 May; 18 (5): 440 - 4. doi: 10.1007/s00467-003-1091-7

223. Kuizon BD, Salusky IB. Intermittent calcitriol therapy and growth in children with chronic renal failure. Miner Electrolyte Metab. 1998; 24 (4): 290 - 5. doi: 10.1159/000057384

224. Gutzwiller JP, Schneditz D, Huber AR, et al. Increasing blood flow increases kt/V(urea) and potassium removal but fails to improve phosphate removal. Clin Nephrol. 2003 Feb; 59 (2): 130 - 6. doi: 10.5414/cnp59130. PMID: 12608556

225. Vaithilingam I, Polkinghorne KR, Atkins RC, Kerr PG. Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis. 2004 Jan; 43(1): 85 - 9. doi: 10.1053/j.ajkd.2003.09.016. PMID: 14712431

226. Gutzwiller JP, Schneditz D, Huber AR, et al. Estimating phosphate removal in haemodialysis: an additional tool to quantify dialysis dose. Nephrol Dial Transplant. 2002 Jun; 17 (6): 1037 - 44. doi: 10.1093/ndt/17.6.1037. PMID: 12032194

227. Ketteler M. et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters//Kidney international. - 2017. - T. 92. - N. 1. - С. 26 - 36. - 5C

228. Ruospo M, Palmer SC, Natale P, et al. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database Syst Rev. 2018 Aug 22; 8 (8): CD006023. doi: 10.1002/14651858.CD006023.pub3. PMID: 30132304; PMCID: PMC6513594

229. Habbous S, Przech S, Acedillo R, et al. The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2017 Jan 1; 32(1): 111 - 125. doi: 10.1093/ndt/gfw312. PMID: 27651467

230. Sanchez C.P. Secondary Hyperparathyroidism in Children with Chronic Renal Failure//Pediatric Drugs. - 2003. - T. 5. - N 11. - С. 763 - 776.

231. Wesseling-Perry K., Salusky I.B. Chronic kidney disease: mineral and bone disorder in children//Seminars in nephrology. - WB Saunders, 2013. - T. 33. - N 2. - С. 169 - 179.

232. Schlosser K, Schmitt CP, Bartholomaeus JE, et al. Parathyroidectomy for renal hyperparathyroidism in children and adolescents. World J Surg. 2008 May; 32 (5): 801 - 6. doi: 10.1007/s00268-007-9318-6. PMID: 18064514. - 4C

233. Rees, L. What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence? Pediatr Nephrol 23, 179 - 184 (2008).

234. Geng S, Kuang Z, Peissig PL, Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease. Osteoporos Int. 2019 Oct; 30 (10): 2019 - 2025. doi: 10.1007/s00198-019-05033-3. Epub 2019 May 31. PMID: 31190122

235. Shardlow A, McIntyre NJ, Fluck RJ. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3. BMJ Open. 2017 Aug 23; 7 (8): e016528. doi: 10.1136/bmjopen-2017-016528. PMID: 28838895; PMCID: PMC5629682

236. Seiler-Mussler S, Limbach AS, Emrich IE, et al. Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2018 Apr 6; 13 (4): 569 - 576. doi: 10.2215/CJN.06620617. Epub 2018 Mar 5. PMID: 29507005; PMCID: PMC5968904

237. Tentori F, Wang M, Bieber BA, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015 Jan 7; 10 (1): 98 - 109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16. PMID: 25516917; PMCID: PMC4284424

238. Tentori F, Zepel L, Fuller DS, et al. The DOPPS Practice Monitor for US Dialysis Care: PTH Levels and Management of Mineral and Bone Disorder in US Hemodialysis Patients. Am J Kidney Dis. 2015 Sep; 66 (3): 536 - 9. doi: 10.1053/j.ajkd.2015.07.011. PMID: 26300197; PMCID: PMC5436274

239. Natoli JL, Boer R, Nathanson BH, et al. Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis. BMC Nephrol. 2013 Apr 17; 14: 88. doi: 10.1186/1471-2369-14-88. PMID: 23594621; PMCID: PMC3658973

240. Schneider R, Kolios G, Koch BM, et al. An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism - the German perspective. Surgery. 2010 Dec; 148 (6): 1091 - 9. doi: 10.1016/j.surg.2010.09.009. PMID: 21134538

241. Narayan R, Perkins RM, Berbano EP, et al. Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis. 2007 Jun; 49 (6): 801 - 13. doi: 10.1053/j.ajkd.2007.03.009. PMID: 17533023

242. El-Husseini AA, El-Agroudy AE, El-Sayed M, et al. A prospective randomized study for the treatment of bone loss with vitamin d during kidney transplantation in children and adolescents. Am J Transplant. 2004 Dec; 4 (12): 2052 - 7. doi: 10.1111/j.1600-6143.2004.00618.x

243. Boyce, A.M. Denosumab: an Emerging Therapy in Pediatric Bone Disorders. Curr Osteoporos Rep 15, 283 - 292 (2017). https://doi.org/10.1007/s11914-017-0380-1

244. Palmer SC, Chung EY, McGregor DO, Bachmann F, Strippoli GF. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev. 2019 Oct 22; 10 (10): CD005015

245. Holden RM, Mustafa RA, Alexander RT, et al. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder. Can J Kidney Health Dis. 2020 Aug 4; 7: 2054358120944271. doi: 10.1177/2054358120944271. PMID: 32821415; PMCID: PMC7412914

246. Kari JA, Gonzalez C, Ledermann SE, et al. Outcome and growth of infants with severe chronic renal failure. Kidney Int. 2000 Apr; 57 (4): 1681 - 7. doi: 10.1046/j.1523-1755.2000.00013.x. PMID: 10760104

247. Borzych D, Rees L, Ha IS, et al; International Pediatric PD Network (IPPN). The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 2010 Dec; 78 (12): 1295 - 304. doi: 10.1038/ki.2010.316. Epub 2010 Sep 1. PMID: 20811335

248. Watkins SL. Is severe renal osteodystrophy a contraindication for recombinant human growth hormone treatment? Pediatr Nephrol. 1996 Jun; 10 (3): 351 - 4. doi: 10.1007/BF00866781. PMID: 8792404

249. European Medicines Agency. Summary of product characteristics. EMA https://www.ema.europa.eu/en/documents/product-information/omnitropeepar-product-information_en.pdf (updated 6 Mar 2018)

250. Kleinknecht C, Broyer M, Huot D, Marti-Henneberg C, Dartois AM. Growth and development of nondialyzed children with chronic renal failure. Kidney Int Suppl. 1983 Nov; 15: S40 - 7. PMID: 6584675

251. National Kidney Foundation. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Am. J. Kidney Dis. 53 (Suppl. 3), 1 - 126 (2009)

252. Haffner D, E, Schaefer F, et al. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. J Am Soc Nephrol. 1998 Oct; 9 (10): 1899 - 907. doi: 10.1681/ASN.V9101899. PMID: 9773791

253. E, Haffner D, Nissel R, et al. Short dialyzed children respond less to growth hormone than patients prior to dialysis. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol. 1996 Jun; 10 (3): 294 - 8. doi: 10.1007/BF00866763. PMID: 8792393

254. Zhang H, Zheng Y, Liu L, et al. Steroid Avoidance or Withdrawal Regimens in Paediatric Kidney Transplantation: A Meta-Analysis of Randomised Controlled Trials. PLoS One. 2016 Mar 18; 11 (3): e0146523. doi: 10.1371/journal.pone.0146523. PMID: 26991793; PMCID: PMC4798578

255. Wu Y, Cheng W, Yang XD, Xiang B. Growth hormone improves growth in pediatric renal transplant recipients - a systemic review and meta-analysis of randomized controlled trials. Pediatr Nephrol. 2013 Jan; 28 (1): 129 - 33. doi: 10.1007/s00467-012-2208-7. Epub 2012 Jun 4. PMID: 22660958

256. Fine RN, Stablein D. Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry. Pediatr Nephrol. 2005 Mar; 20 (3): 404 - 8. doi: 10.1007/s00467-004-1688-5. Epub 2005 Jan 29. PMID: 15682317

257. Hodson EM, Willis NS, Craig JC. Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev. 2012 Feb 15; 2012 (2): CD003264. doi: 10.1002/14651858.CD003264.pub3. PMID: 22336787; PMCID: PMC6599873

258. Fine RN, Brown DF, Kuntze J, et al. Growth after discontinuation of recombinant human growth hormone therapy in children with chronic renal insufficiency. The Genentech Cooperative Study Group. J Pediatr. 1996 Dec; 129 (6): 883 - 91. doi: 10.1016/s0022-3476(96)70033-1. PMID: 8969731

259. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. National Kidney Foundation. Am J Kidney Dis. 2015; 66 (5): 884

260. Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis. Nesrallah GE, Mustafa RA, Clark WF, Bass A, Barnieh L, Hemmelgarn BR, Klarenbach S, Quinn RR, Hiremath S, Ravani P, Sood MM, Moist LM, Canadian Society of Nephrology. CMAJ. 2014 Feb; 186 (2): 112 - 7

261. Urgent-Start Peritoneal Dialysis and Hemodialysis in ESRD Patients: Complications and Outcomes. Jin H, Fang W, Zhu M, et al. 2016; 11 (11): e0166181. Epub 2016 Nov 8.

262. Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis. Koch M, Kohnle M, Trapp R, et al. Nephrol Dial Transplant. 2012 Jan; 27 (1): 375 - 80. Epub 2011 May 28.

263. Augustine J. Kidney transplant: New opportunities and challenges. Clin. J. Med. 2018 Feb; 85(2): 138 - 144.

264. Horslen S., Barr M.L., Christensen L.L., Ettenger R., Magee J.C. Pediatric transplantation in the United States, 1996 - 2005. Am. J. Transplant. 2007; 7: 1339 - 58.

265. Harmon W.E. Pediatric kidney transplantation. In: Avner ED, Harmon W.E., Niaudet P., Yoshikawa N., eds. Pediatric nephrology. 6th ed. Berlin: Springer-Verlag, 2009: 1867 - 902.

266. Benedict L. Phillips 1 & Chris J. Callaghan. Graft nephrectomy in children. Pediatr. Nephrol. (2018) 33: 947 - 955

267. Vikas R. Dharnidharka, Paolo Fiorina, Ph. D., and William E. Harmon. Kidney Transplantation in Children. N. Engl. J. Med. 2014; 371: 549 - 58.

268. Amaral S, Sayed BA, Kutner N, Patzer RE. Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease. Kidney Int. 2016 Nov; 90 (5): 1100 - 1108. doi: 10.1016/j.kint.2016.07.028. Epub 2016 Sep 18. PMID: 27653837; PMCID: PMC5072842

269. Wilkinson TM, Dittmer ID. Should Children Be Given Priority in Kidney Allocation? J Bioeth Inq. 2016 Dec; 13 (4): 535 - 545. doi: 10.1007/s11673-016-9737-x. Epub 2016 Jul 8. PMID: 27392661

270. Stojanovic J, Mamode N, Adamusiak A, et al G473 Outcomes of abo incompatible kidney transplantation in children Archives of Disease in Childhood 2015; 100: A199 - A200

271. Fehr T, Stussi G. ABO-incompatible kidney transplantation. Curr Opin Organ Transplant. 2012 Aug; 17 (4): 376 - 85. doi: 10.1097/MOT.0b013e328355f013. PMID: 22790072.

272. Данович Габриэль М. Трансплантация почки, ред. ЯГ Мойсюк ГЭОТАР-Медиа, М., 2013; 23 - 138 [Danovitch Gabriel M Handbook of kidney transplantation, ed. YG Moisyuk GEOTARMedia, M, 2013; 23 - 138.

273. Vo AA, Choi J, Cisneros K, et al. Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients. Transplantation 2014; 98: 312

274. Locke JE, Mehta S, Reed RD, et al. A National Study of Outcomes among HIV-infected Kidney Transplant Recipients. J Am Soc Nephrol 2015; 26: 2222

275. Roland ME, Barin B, Huprikar S, et al. Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS 2016; 30: 435

276. Sagmeister MS, Grigorescu M, U. Kidney transplantation in ANCA-associated vasculitis. J Nephrol. 2019 Dec; 32 (6): 919 - 926. doi: 10.1007/s40620-019-00642-x. Epub 2019 Aug 30. PMID: 31471816

277. Kostopoulou M, Fanouriakis A, Cheema K, et al. Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association - European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations. RMD Open. 2020 Jul; 6 (2): e001263. doi: 10.1136/rmdopen-2020-001263. PMID: 32699043; PMCID: PMC7425195.

278. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care. Heemann U, Pascual J, Dudley C, Harden P, Hourmant M, Maggiore U, Salvadori M, Spasovski G, Squifflet JP, Steiger J, Torres A, Viklicky O, Zeier M, Vanholder R, Van Biesen W, Nagler E. Nephrol Dial Transplant. 2015; 30 (11): 1790

279. Ventola CL (2016) Immunization in the United States: recommendations, barriers, and measures to improve compliance: part 1: childhood vaccinations. P T 41: 426 - 436

280. Rubin L, Levin M, Ljungman P, et al. (2014) 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 58: 309 - 318

281. Kroger AT, Duchin J, Vazquez M. General Best Practice Guidelines for Immunization. Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). 2017. Available at: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html. Accessed August 20, 2017

282. Exp Clin Transplant. 2018 Dec; 16 (6): 660 - 664. doi: 10.6002/ect.2016.0360. Epub 2017 Sep 26. Renal Transplant in Abnormal Bladder: Treatment Options and Their Effects on Graft Outcome. Baher Salman, Ahmed Hassan, Mohamed Selim, Tarek Abdelbaky, Sultan Sultan, Ahmed Halawa

283. Mitchell ME, Balcom AH. Bladder dysfunction in children. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, eds. Pediatric nephrology. 6th ed. Berlin: Springer-Verlag, 2009: 1379 - 404.

284. Transl Androl Urol. 2019 Apr; 8 (2): 134 - 140. doi: 10.21037/tau.2018.06.17. Urologic issues in pediatric transplant recipients. Fabio C M Torricelli, Andrea Watanabe, Affonso C Piovesan, Elias David-Neto, William C Nahas. PMID: 31080773 PMCID: PMC6503233 DOI: 10.21037/tau.2018.06.17

285. Vats AN, Donaldson L, Fine RN, Chavers B. Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS study. Transplantation 2000; 69: 1414 - 1419

286. Dharnidharka VR, Fiorina P, Harmon WE. Kidney transplantation in children. N Engl J Med. 2014 Aug 7; 371 (6): 549 - 58. doi: 10.1056/NEJMra1314376. PMID: 25099579

287. Ramay BM, A, LP, Lou-Meda R. Factors associated to acceptable treatment adherence among children with chronic kidney disease in Guatemala. PLoS One. 2017 Oct 16; 12 (10): e0186644. doi: 10.1371/journal.pone.0186644

288. Vats AN, Donaldson L, Fine RN, Chavers BM. Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study. Transplantation. 2000 Apr 15; 69 (7): 1414 - 9. doi: 10.1097/00007890-200004150-00035. PMID: 10798764

289. Benfield MR, Stablein D, Tejani A. Trends in immuno-suppressive therapy: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999; 3: 27 - 32

290. Muntean A. Immunosuppression in kidney transplantation. Clujul Med. 2013; 86: 177 - 180. Thaunat O. Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppression. Kidney Int. 2015; 88: 1226 - 1228.

291. The North American Pediatric Renal Trials and Collaborative Studies 2014 Annual Report. Available at: https://web.emmes.com/study/ped/annlrept/annlrept.html (Accessed on October 02, 2015)

292. Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population. Van Stralen KJ, Verrina E, Belingheri M, Dudley J, Dusek J, Grenda R, Macher MA, Puretic Z, Rubic J, Rudaitis S, Rudin C, Schaefer F, Jager KJ, ESPN/ERA-EDTA Registry Nephrol Dial Transplant. 2013 Apr; 28 (4): 1031 - 8. Epub 2013 Jan 8

293. Nelms ChL, Shaw V, Greenbaum LA et al. Assesment of nutritional status in children with kidney diseases - clinical practice recommendations from the Pediatric Renal Nutrition Taskforce/Pediatr Nephrol (2021) 36: 995 - 1010

294. R, D, AJ. Is too much salt harmful? Yes. Pediatr Nephrol. 2020 Sep; 35 (9): 1777 - 1785. doi: 10.1007/s00467-019-04387-4. Epub 2019 Nov 28. PMID: 31781959; PMCID: PMC7384997

295. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006; 47: S1 - S146

296. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target. Am J Kidney Dis. 2007; 50: 471 - 530

297. Chronic kidney disease in children: Overview of management https://www.uptodate.com/contents/6085, last updated: Jan 13, 2021

298. Low Birth Weight and Nephron Number Working Group. The Impact of Kidney Development on the Life Course: A Consensus Document for Action. Nephron. 2017; 136 (1): 3 - 49. doi: 10.1159/000457967. Epub 2017 Mar 21. PMID: 28319949; PMCID: PMC5472217

299. Cerqueira DC, Soares CM, Silva VR, et al. A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program. Clin J Am Soc Nephrol. 2014 Apr; 9 (4): 728 - 35. doi: 10.2215/CJN.06630613. Epub 2014 Jan 23. PMID: 24458086; PMCID: PMC3974357

300. Saran R, Li Y, Robinson B, et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2015 Jul; 66 (1 Suppl 1): Svii, S1 - 305. doi: 10.1053/j.ajkd.2015.05.001. Erratum in: Am J Kidney Dis. 2015 Sep; 66 (3): 545. Erratum in: Am J Kidney Dis. 2015 Sep; 66 (3): 545. PMID: 26111994; PMCID: PMC6643986

301. Wong CS, Pierce CB, Cole SR, et al; CKiD Investigators. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol. 2009 Apr; 4 (4): 812 - 9. doi: 10.2215/CJN.01780408. Epub 2009 Mar 18. PMID: 19297612; PMCID: PMC2666424

302. Starr MC, Hingorani SR. Prematurity and future kidney health: the growing risk of chronic kidney disease. Curr Opin Pediatr. 2018 Apr; 30 (2): 228 - 235. doi: 10.1097/MOP.0000000000000607. PMID: 29432217; PMCID: PMC6085891

303. Jetton JG, Boohaker LJ, Sethi SK, et al; Neonatal Kidney Collaborative (NKC). Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health. 2017 Nov; 1(3): 184 - 194. doi: 10.1016/S2352-4642(17)30069-X. PMID: 29732396; PMCID: PMC5933049

304. Eriksson JG, Salonen MK, Kajantie E, Osmond C. Prenatal Growth and CKD in Older Adults: Longitudinal Findings From the Helsinki Birth Cohort Study, 1924 - 1944. Am J Kidney Dis. 2017 Aug 22. This large registry-based study provides evidence that lower birth weight and prematurity are associated with an increased risk of CKD

305. Khalsa DDK, Beydoun HA, Carmody JB. Prevalence of chronic kidney disease risk factors among low birth weight adolescents. Pediatr Nephrol. 2016; 31 (9): 1509 - 16

306. Keijzer-Veen MG, Devos AS, Meradji M, et al. Reduced renal length and volume 20 years after very preterm birth. Pediatr Nephrol. 2009; 25 (3): 499 - 507.

307. Harada R, Hamasaki Y, Okuda Y, Hamada R, Ishikura K. Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies. Pediatr Nephrol. 2021 Jun 6. doi: 10.1007/s00467-021-05145-1. Epub ahead of print. PMID: 34091754

308. Ardissino G, Testa S, V, et al. Puberty is associated with increased deterioration of renal function in patients with CKD: data from the ItalKid Project. Arch Dis Child. 2012 Oct; 97 (10): 885 - 8. doi: 10.1136/archdischild-2011-300685. Epub 2012 Jul 25. PMID: 22833407

309. Furtha S.L., Moxey-Mimsb M., Ruebnerc R. Chronic Kidney Disease in Children in "Chronic Renal Disease", Second Edition. 2020 https://doi.org/10.1016/B978-0-12-815876-0.00075-9

310. Национальная программа "Недостаточность витамина D у детей и подростков Российской Федерации: современные подходы к коррекции" Союз педиатров России. 2018.

311. Rees L., Bockenhauer D., Webb N.J.A., Punaro M.G. Hypertension. In: Pediatric nephrology, 3d edition. Oxford University Press, 2019, pp 389 - 412

312. Avitabile CM, Vorhies EE, Ivy DD. Drug Treatment of Pulmonary Hypertension in Children. Paediatr Drugs. 2020 Apr; 22 (2): 123 - 147.

313. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=ed61ac51-2908-4441-a7a7-3167b552d091&t=

314. Nayak P., Sinha M.D. (2018) Renal Emergencies in PICU: Electrolyte, Acid Base and Blood Pressure Issues. In: Deep A., Goldstein S. (eds) Critical Care Nephrology and Renal Replacement Therapy in Children. Springer, Cham. https://doi.org/10.1007/978-3-319-90281-4_11

315. Management of hyperkalemia in children https://www.uptodate.com/contents/management-of-hyperkalemia-in-children?search=Management%20of%20hyperkalemia%20in%20children&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 This topic last updated: Jun 02, 2020.